Restructuring and Survival Signals: How 10 Off-the-Radar Stocks Are Navigating the Capital PivotGlobal Report·Jul 8 at 10:32 PMJZ+14.10%UAVS-2.00%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 8 at 12:05 PMCUPR+0.30%TVRD-7.25%
11 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 2 at 12:05 PMLIMN-2.70%ELTX+0.96%
Top Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watchrttnews·Jul 1 at 10:22 PMCANF-2.12%ELTX+0.96%
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering | ELTX Stock NewsStockTitan·Jul 1 at 03:25 PMELTX+0.96%
Elicio Therapeutics Added to Russell 2000® and Russell 3000® IndexesUnusual Whales·Jun 29 at 07:02 AMELTX+0.96%
Elicio Therapeutics posts AMPLIFY-7P presentation on ELI-002 7P in metastatic mKRAS pancreatic cancerPUBT·Jun 25 at 07:06 AMELTX+0.96%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jun 18 at 12:06 PMATPC+1.98%APLM+1.40%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jun 18 at 07:06 AMLNAI-11.11%NVCR+28.39%
U.S. stock night market volatility: KRAS vaccine phase II failure causes stock price to plummet 73%, further decline of 14% in night tradingPrice Alert·Jun 17 at 07:16 PMELTX+0.96%
U.S. stock night trading opened with fluctuations: Elicio Therapeutics fell 15.92% in night trading; Arm rose 4.35% in night tradingPrice Alert·Jun 17 at 07:11 PMELTX+0.96%ARM-0.13%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jun 17 at 04:06 PMADTX+6.06%NRSN+0.77%
Elicio Therapeutics Falls 13% After Hours as Pancreatic Cancer Drug Data Draws FocusUS Stock Market Update·Jun 17 at 04:00 PMELTX+0.96%
